TY - JOUR
T1 - Long-term risk of allergic diseases after allergic proctocolitis
AU - Kazancioglu, Alp
AU - Ozdemiral, Cansu
AU - Gur Cetinkaya, Pinar
AU - Ocak, Melike
AU - Sahiner, Umit Murat
AU - Sekerel, Bulent Enis
AU - Soyer, Ozge
N1 - Publisher Copyright:
© 2025 American College of Allergy, Asthma & Immunology.
PY - 2025/12
Y1 - 2025/12
N2 - Background The long-term progression of allergic conditions in children with a history of food protein-induced allergic proctocolitis (FPIAP) remains unclear. Objective To assess the prevalence and clinical characteristics of allergic diseases, particularly asthma, in patients with a history of FPIAP. Methods In this retrospective case-control study, we included 170 patients diagnosed with having FPIAP (median age [IQR]: 7.4 [6.9-8.0] years) who developed tolerance at a median age of 12 months (IQR: 10.0-14.0). Control groups comprised patients with non-food allergy (non-FA; n = 101), outgrown IgE-mediated cow’s milk allergy (IgE-CMA; n = 97), and current IgE-CMA (n = 100). The proportions of asthma and allergic rhinitis (AR) were compared among the groups. Results The FPIAP group exhibited a higher risk of developing asthma and AR than the non-FA group did (asthma: adjusted odds ratio: 4.273, 95% CI: 2.173-8.403, P < .001; AR: adjusted odds ratio: 3.039, 95% CI: 1.199-7.692, P = .019). The proportions of asthma and AR in the FPIAP group (45.2% and 17.6%, respectively) were significantly higher than those in the non-FA group (12.9%, P < .001; 5.9%, P = .006) but lower than those in the current IgE-CMA group (74%, P < .001; 36%, P = .001). No significant differences were observed between the FPIAP and outgrown IgE-CMA groups. However, patients with FPIAP exhibited poorer asthma control than those in the IgE-mediated CMA groups did. Conclusion Children with a history of FPIAP are at an increased risk of developing asthma and AR, necessitating ongoing monitoring. Further research is needed to clarify the role of FPIAP in the allergic march.
AB - Background The long-term progression of allergic conditions in children with a history of food protein-induced allergic proctocolitis (FPIAP) remains unclear. Objective To assess the prevalence and clinical characteristics of allergic diseases, particularly asthma, in patients with a history of FPIAP. Methods In this retrospective case-control study, we included 170 patients diagnosed with having FPIAP (median age [IQR]: 7.4 [6.9-8.0] years) who developed tolerance at a median age of 12 months (IQR: 10.0-14.0). Control groups comprised patients with non-food allergy (non-FA; n = 101), outgrown IgE-mediated cow’s milk allergy (IgE-CMA; n = 97), and current IgE-CMA (n = 100). The proportions of asthma and allergic rhinitis (AR) were compared among the groups. Results The FPIAP group exhibited a higher risk of developing asthma and AR than the non-FA group did (asthma: adjusted odds ratio: 4.273, 95% CI: 2.173-8.403, P < .001; AR: adjusted odds ratio: 3.039, 95% CI: 1.199-7.692, P = .019). The proportions of asthma and AR in the FPIAP group (45.2% and 17.6%, respectively) were significantly higher than those in the non-FA group (12.9%, P < .001; 5.9%, P = .006) but lower than those in the current IgE-CMA group (74%, P < .001; 36%, P = .001). No significant differences were observed between the FPIAP and outgrown IgE-CMA groups. However, patients with FPIAP exhibited poorer asthma control than those in the IgE-mediated CMA groups did. Conclusion Children with a history of FPIAP are at an increased risk of developing asthma and AR, necessitating ongoing monitoring. Further research is needed to clarify the role of FPIAP in the allergic march.
UR - https://www.scopus.com/pages/publications/105013656404
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:001630611500016&DestLinkType=FullRecord&DestApp=WOS_CPL
U2 - 10.1016/j.anai.2025.07.014
DO - 10.1016/j.anai.2025.07.014
M3 - Article
C2 - 40701364
AN - SCOPUS:105013656404
SN - 1081-1206
VL - 135
SP - 689-695.e3
JO - Annals of Allergy, Asthma and Immunology
JF - Annals of Allergy, Asthma and Immunology
IS - 6
ER -